AIM: To evaluate the effects of OGG1 (Ser326Cys, 11657A/G, and Arg154His) and APE1 (Asp148Glu, and T-656G) polymorphisms on colorectal cancer (CRC) risk. METHODS: We enrolled 727 cases newly diagnosed with colorectal adenocarcinoma and 736 age- and sex-matched healthy controls from a medical center in Taiwan. Genomic DNA isolated from the buffy coat was used for genotyping through polymerase chain reaction. Unconditional logistic regressions were used for calculating ORs and 95%CIs to determine the association between the genetic polymorphisms and CRC risk. Haplotype frequencies were estimated using PHASE software. Moreover, stratification analyses on the basis of sex, age at diagnosis, and tumor subsite and stage were performed. RESULTS: The CRC risk was higher in patients with the OGG1 326Ser/Cys + Cys/Cys genotype (OR = 1.38, 95%CI: 1.03-1.85, P = 0.030), particularly high in patients with stage III + IV cancer (OR = 1.48, 95%CI: 1.03-2.13) compared with patients with the Ser/Ser genotype. In addition, OGG1 11657G allele carriers had a 41% reduced CRC risk among stage 0-II patients (OR = 0.59, 95%CI: 0.35-0.98). The CRC risk was significantly higher among females with the APE1 Glu allele (OR = 1.41, 95%CI: 1.02-1.96). The APE1 148Glu/-656G haplotype was also associated with a significant CRC risk in females (OR = 1.36, 95%CI: 1.03-1.78). CONCLUSION: OGG1 and APE1 polymorphisms are associated with stage- and sex-specific risk of CRC in the Taiwanese population.
AIM: To evaluate the effects of OGG1 (Ser326Cys, 11657A/G, and Arg154His) and APE1 (Asp148Glu, and T-656G) polymorphisms on colorectal cancer (CRC) risk. METHODS: We enrolled 727 cases newly diagnosed with colorectal adenocarcinoma and 736 age- and sex-matched healthy controls from a medical center in Taiwan. Genomic DNA isolated from the buffy coat was used for genotyping through polymerase chain reaction. Unconditional logistic regressions were used for calculating ORs and 95%CIs to determine the association between the genetic polymorphisms and CRC risk. Haplotype frequencies were estimated using PHASE software. Moreover, stratification analyses on the basis of sex, age at diagnosis, and tumor subsite and stage were performed. RESULTS: The CRC risk was higher in patients with the OGG1326Ser/Cys + Cys/Cys genotype (OR = 1.38, 95%CI: 1.03-1.85, P = 0.030), particularly high in patients with stage III + IV cancer (OR = 1.48, 95%CI: 1.03-2.13) compared with patients with the Ser/Ser genotype. In addition, OGG1 11657G allele carriers had a 41% reduced CRC risk among stage 0-II patients (OR = 0.59, 95%CI: 0.35-0.98). The CRC risk was significantly higher among females with the APE1 Glu allele (OR = 1.41, 95%CI: 1.02-1.96). The APE1 148Glu/-656G haplotype was also associated with a significant CRC risk in females (OR = 1.36, 95%CI: 1.03-1.78). CONCLUSION:OGG1 and APE1 polymorphisms are associated with stage- and sex-specific risk of CRC in the Taiwanese population.
Authors: Tomasz Obtulowicz; Maja Swoboda; Elzbieta Speina; Daniel Gackowski; Rafal Rozalski; Agnieszka Siomek; Justyna Janik; Beata Janowska; Jaroslaw M Ciesla; Arkadiusz Jawien; Zbigniew Banaszkiewicz; Jolanta Guz; Tomasz Dziaman; Anna Szpila; Ryszard Olinski; Barbara Tudek Journal: Mutagenesis Date: 2010-06-09 Impact factor: 3.000
Authors: Pilar Garre; Verónica Briceño; Rosa M Xicola; Brian J Doyle; Miguel de la Hoya; Julián Sanz; Patricia Llovet; Paula Pescador; Javier Puente; Eduardo Díaz-Rubio; Xavier Llor; Trinidad Caldés Journal: Clin Cancer Res Date: 2011-02-25 Impact factor: 12.531
Authors: Seyed Mohammad Hosseini; Javad Mohammadiasl; Abdulhasan Talaiezadeh; Rahim Alidadi; Mahdi Bijanzadeh Journal: Asian Pac J Cancer Prev Date: 2020-07-01
Authors: Felipe Antonio de Oliveira Garcia; Edilene Santos de Andrade; Henrique de Campos Reis Galvão; Cristina da Silva Sábato; Natália Campacci; Andre Escremin de Paula; Adriane Feijó Evangelista; Iara Viana Vidigal Santana; Matias Eliseo Melendez; Rui Manuel Reis; Edenir Inez Palmero Journal: Sci Rep Date: 2022-02-18 Impact factor: 4.379